Emtricitabine And Tenofovir Disoproxil Fumarate Tablet, Film Coated
Product Images NDC 82009-109

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Emtricitabine And Tenofovir Disoproxil Fumarate (NDC 82009-109). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Quallent Pharmaceuticals Health Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (200 mg/300 mg (30 Tablet Bottle))

Package Label-principal Display Panel (200 mg/300 mg (30 Tablet Bottle))
Emtricitabine and Tenofovir Disoproxil Fumarate Tablets is a medication that contains 200 mg of Emtricitabine and 300 mg of Tenofovir Disoproxil Fumarate, equivalent to Tenofovir Isoproxil 245 mg, per film-coated tablet. It should be stored at 20°C to 25°C (66°F to 77°F). The medication guide must be dispensed separately to each patient. This medication is manufactured by Aurobindo Pharma Limited, Hyderabad-500 090, India, and distributed by Quallent Pharmaceuticals Health LLC, Grand Cayman, Cayman Islands. The usual dosage should be referred to in the package insert. The container must be tightly closed and the medication must be dispensed only in the original container. The product comes in a pack of 30 tablets, identified by NDC 82009-109-30. Information such as GTIN, Serial Number, Expiry Date, and LOT will be printed during the packing period.*
FDA Label Image

Chemical Structure-1 (Emtriteno Str1)

FDA Label Image

Chemical Structure-2 (Emtriteno Str2)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.